Kent, A., Vasu, S., Schatz, D., Monson, N., Devine, S., Smith, C., . . . Pollyea, D. A. (2020). Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse. Blood Adv.

Kent, Andrew, Sumithira Vasu, Derek Schatz, Natalie Monson, Steven Devine, Clayton Smith, Jonathan A. Gutman, and Daniel A. Pollyea. "Glasdegib As Maintenance Therapy for Patients With AML and MDS Patients At High Risk for Postallogeneic Stem Cell Transplant Relapse." Blood Adv 2020.

Kent, Andrew, et al. "Glasdegib As Maintenance Therapy for Patients With AML and MDS Patients At High Risk for Postallogeneic Stem Cell Transplant Relapse." Blood Adv 2020.